Company Filing History:
1 out of 2 
1 out of 1,027 
1 out of 282 
Years Active: 2018-2020
Title: The Innovative Mind of Pertti Pellinen: Advances in Ocular Health
Introduction: Pertti Pellinen, an esteemed inventor from Lempaala, Finland, has made significant contributions to the field of ophthalmology. With two patents to his name, Pellinen's work primarily addresses the treatment of ocular hypertension and glaucoma, demonstrating his commitment to improving patient care through innovation.
Latest Patents: Pellinen's latest inventions include a method and composition for treating ocular hypertension and glaucoma. These ophthalmic aqueous compositions contain PGF2α analogues, designed to increase aqueous solubility and stability. His innovative approach not only aims to treat these eye conditions effectively but also provides a method for administering this composition to subjects in need, showcasing his dedication to advancing medical therapies.
Career Highlights: Throughout his career, Pertti Pellinen has worked with reputable companies, including Santen Pharmaceutical Co., Ltd. and AGC Inc. His experience at these organizations has allowed him to refine his expertise in pharmaceuticals and contribute to groundbreaking developments in the industry.
Collaborations: In addition to his work in the pharmaceutical sector, Pellinen has collaborated with notable individuals such as Timo Reunamaki and Olli Oksala. These partnerships have likely fostered an environment of innovation, allowing for the exchange of ideas and collaborative problem-solving in the quest to improve human health.
Conclusion: Pertti Pellinen stands out as a significant figure in the field of ophthalmology. His inventions related to ocular hypertension and glaucoma highlight his innovative spirit and dedication to enhancing treatment options. With his continued efforts and collaborations, Pellinen is poised to impact the healthcare landscape positively.